Sort   by:  
 Page size 
UnknownDetection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor.
Not available
S-EPMC7656545 | biostudies-literature
UnknownFibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
Not available
S-EPMC9633314 | biostudies-literature
UnknownDevelopment of luciferase-based highly sensitive reporters that detect ER-associated protein biogenesis abnormalities.
Not available
S-EPMC11564982 | biostudies-literature
UnknownGSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer.
Not available
S-EPMC8931094 | biostudies-literature
UnknownClinical influence of switching companion diagnostic tests for EGFR-TKs from Therascreen to Cobas v2.
Not available
S-EPMC7952781 | biostudies-literature
UnknownOsimertinib plus platinum-pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study.
Not available
S-EPMC8453202 | biostudies-literature
UnknownSerum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Not available
S-EPMC11544981 | biostudies-literature
UnknownMonitoring epidermal growth factor receptor C797S mutation in Japanese non-small cell lung cancer patients with serial cell-free DNA evaluation using digital droplet PCR.
Not available
S-EPMC8177776 | biostudies-literature
UnknownEfficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion.
Not available
S-EPMC10864115 | biostudies-literature
UnknownClinical characteristics of patients with KRAS mutation detected by liquid biopsy.
Not available
S-EPMC10665783 | biostudies-literature
Sort   by:  
 Page size